According to Agile Therapeutics 's latest financial reports the company's current revenue (TTM) is $21.49 M. In 2022 the company made a revenue of $10.88 M an increase over the years 2021 revenue that were of $4.1 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $19.59 M | 79.99% |
2022 | $10.88 M | 165.36% |
2021 | $4.1 M | 447.66% |
2020 | $0.74 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 417,015.61% | ๐บ๐ธ USA |
Pfizer PFE | $55.09 B | 256,206.12% | ๐บ๐ธ USA |
Merck MRK | $61.40 B | 285,557.13% | ๐บ๐ธ USA |
TherapeuticsMD TXMD | $1.11 M | -94.82% | ๐บ๐ธ USA |
Antares Pharma ATRS | $0.18 B | 755.93% | ๐บ๐ธ USA |